Capmatinib dihydrochloride
CAS: 1197376-85-4
Ref. 3D-XXB37685
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
Capmatinib dihydrochloride is a molecule with antiproliferative, anti-angiogenic and cell death properties. It inhibits the c-met receptor tyrosine kinase, which is involved in tumor growth and angiogenesis. Capmatinib dihydrochloride has been shown to be effective against various cancers including breast cancer, non-small cell lung cancer, and prostate cancer. It also has an affinity for the antibody that targets the c-met receptor tyrosine kinase. This drug also has a patent and is one of the first in a new class of oncology drugs known as selpercatinibs. Capmatinib dihydrochloride can be used as a treatment for cancers that are resistant to other therapies or when other treatments have not worked.
Chemical properties
Technical inquiry about: 3D-XXB37685 Capmatinib dihydrochloride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
